Does Nicotine Affect Your Kidneys? The Detailed Answer

Nicotine harms the kidneys through several distinct pathways, from constricting the blood vessels that supply them to directly damaging the specialized cells that filter your blood. Research in both animals and humans shows that nicotine temporarily reduces kidney blood flow and filtration rate, promotes scarring of kidney tissue, and accelerates the progression of chronic kidney disease, particularly in people with diabetes. The damage is not limited to cigarette smoke; nicotine delivered through e-cigarettes, patches, and oral pouches can also put kidneys at risk, though the evidence varies in strength across delivery methods.

How Nicotine Immediately Changes Kidney Blood Flow

Within minutes of entering your bloodstream, nicotine triggers the sympathetic nervous system, the same fight-or-flight response that raises your heart rate before a job interview. This drives up blood pressure and constricts blood vessels throughout the body, including those inside the kidneys. In healthy non-smokers given nicotine, blood pressure rose while effective kidney blood flow and filtration rate each dropped by roughly 15%.1PubMed Central. Nicotine signaling and progression of chronic kidney disease in smokers Animal studies have confirmed the picture in more detail: nicotine infusion nearly halved total kidney blood flow in dogs, with significant reductions across the outer cortex, inner cortex, and outer medulla.2Life Sciences. Mechanisms mediating canine renal vasoconstriction induced by nicotine infusion That vasoconstriction was driven primarily by the body’s adrenaline-signaling system in the first few minutes, with the hormone angiotensin II contributing a secondary squeeze on the outer cortex.

These acute drops in blood flow are temporary in isolation, but repeated daily over months and years they add up. Each episode of reduced blood flow is a small ischemic insult, a momentary deprivation of oxygen that kidney tissue is poorly equipped to tolerate over time. This helps explain why habitual smoking is an independent risk factor for chronic kidney disease even in people who have no other obvious kidney problems.

Chronic Smokers Develop Tolerance, but It Is Not Protective

An interesting wrinkle in the research is that regular smokers seem to develop a tolerance to nicotine’s acute kidney effects. In a study comparing smokers and non-smokers given intravenous nicotine, both groups showed similar spikes in blood pressure and heart rate, but only the non-smokers experienced the drop in kidney blood flow and filtration rate.3Nephrology Dialysis Transplantation. Contrasting renal effects of nicotine in smokers and non-smokers Smokers maintained their kidney blood flow, likely because a protective signaling pathway involving cyclic GMP had adapted to chronic exposure.

That might sound like good news, but it is misleading. The tolerance applies to the acute hemodynamic hit, the brief dip in blood flow you get right after nicotine exposure. It does not protect against the slow-burn cellular damage nicotine causes: oxidative stress, scarring, podocyte loss, and the hormonal changes discussed below. Chronic smokers still develop kidney disease at far higher rates than non-smokers. The tolerance just means the kidneys have found a workaround for the blood-flow problem while remaining vulnerable to everything else nicotine does.

Nicotine Damages the Kidney’s Filtering Cells

Your kidneys filter blood through tiny structures called glomeruli, and the gatekeepers of that filtration are cells called podocytes. These cells wrap around the glomerular capillaries and form the slit diaphragm, essentially the kidney’s sieve. Nicotine at concentrations typical of smoking or e-cigarette use activates an enzyme in podocytes that cranks out damaging reactive oxygen molecules. That sets off a cascade: it boosts an enzyme known to injure podocytes, shuts down a key energy-maintenance pathway, and ramps up lipid uptake in a way that drives cell death. In diabetic mice, nicotine increased protein leaking into the urine, which is a classic marker of kidney disease progression, and reduced a crucial structural protein that keeps podocytes stable.4PubMed Central. Nicotine, smoking, podocytes, and diabetic nephropathy

Separate work has confirmed that nicotine decreases the expression of podocin and nephrin, two proteins that podocytes need to maintain the integrity of the filtration barrier, while increasing desmin, a stress marker, and making the cells more permeable.5PubMed Central. High mobility group box 1 (HMGB1) mediates nicotine-induced podocyte injury In plain terms, nicotine makes the kidney’s filter leakier, which is why protein starts showing up in the urine of exposed animals and eventually humans.

The Receptor That Ties It Together

Much of this damage is mediated through a specific receptor found on kidney cells called the alpha-7 nicotinic acetylcholine receptor. It is the same type of receptor nicotine activates in the brain to produce its addictive effects, but kidney tubule cells express it too.6PubMed Central. Nicotinic acetylcholine receptor expression and regulation in the rat kidney after ischemia-reperfusion injury In rats with surgically reduced kidney mass (a standard model of chronic kidney disease), nicotine working through this receptor roughly doubled protein in the urine, worsened glomerular scarring, and significantly increased oxidative stress markers and a growth factor linked to tissue fibrosis. Blocking the receptor with a drug called MLA prevented all of those effects, confirming that nicotine’s kidney harm runs specifically through this channel.7PubMed Central. Nicotine exposure and the progression of chronic kidney disease: role of the α7-nicotinic acetylcholine receptor

A related receptor, alpha-1, has been implicated in kidney scarring specifically. When activated, it changes the behavior of kidney fibroblasts, turning them into more aggressive cells that proliferate faster and produce excess connective tissue.8Journal of Biological Chemistry. Urokinase initiates renal fibrosis by activating the nicotinic acetylcholine receptor α1 This is the machinery behind fibrosis, the gradual replacement of healthy kidney tissue with scar tissue that cannot filter blood.

Nicotine and the Hormone System That Controls Blood Pressure

Beyond its direct cellular effects, nicotine disrupts the renin-angiotensin system, the hormonal network that regulates blood pressure and fluid balance. Nicotine pushes the system toward its harmful arm, ramping up angiotensin II (which constricts blood vessels and promotes inflammation) while suppressing the protective counter-arm that would normally keep things in balance.9PubMed Central. Nicotine and the renin-angiotensin system For the kidneys, this means more sustained vasoconstriction, more inflammation, and more pressure on the glomeruli over time. It is one of the reasons smoking and high blood pressure so often travel together and jointly accelerate kidney decline.10Turkish Journal of Nephrology. Smoking and Chronic Kidney Disease

Why Diabetes Makes the Kidney Damage Much Worse

If nicotine is harmful to healthy kidneys, it is far more destructive to kidneys already stressed by diabetes. This is a clinically important point because diabetic kidney disease is the leading cause of kidney failure worldwide, and a significant fraction of people with diabetes also smoke or use nicotine products.

In diabetic mice, nicotine roughly doubled urinary protein excretion and expanded the scarring area within the glomeruli by about 20%, changes that did not occur to the same degree in non-diabetic animals receiving the same nicotine dose.11PubMed Central. Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers Further research has identified a specific gene, Grem1, that nicotine upregulates only in the presence of high blood sugar. Nicotine alone did not cause obvious kidney injury in the study animals, but the combination of nicotine and elevated blood sugar significantly increased albuminuria, blood urea nitrogen, and markers of tubular damage.12PubMed Central. Nicotine exacerbates diabetic nephropathy through upregulation of Grem1 expression The takeaway: nicotine and diabetes have a synergistic relationship where each amplifies the other’s kidney damage.

A large cross-sectional analysis of adults who smoke found that the rate at which a person metabolizes nicotine also matters. Faster nicotine metabolism was associated with lower kidney filtration rates, and the effect was larger in people with diabetes (about 4.5 units lower filtration rate per unit increase in the nicotine metabolite ratio) and in people over 60 (about 6 units lower).13PubMed Central. The hidden impact: the rate of nicotine metabolism and kidney health In other words, if you metabolize nicotine quickly, your kidneys may face a heavier burden, possibly because the liver produces more of the metabolites that circulate through the kidneys.

Nicotine Makes Kidneys More Vulnerable to Sudden Injury

Beyond chronic disease progression, nicotine appears to sensitize the kidneys to acute injury. In a mouse model, chronic nicotine exposure worsened the damage caused by a brief period of ischemia (interrupted blood flow, similar to what happens during certain surgeries or episodes of very low blood pressure). Nicotine-exposed kidneys showed more structural damage, higher creatinine levels, and increased expression of a kidney-injury marker compared with kidneys from non-exposed animals.14PubMed Central. Chronic nicotine exposure exacerbates acute renal ischemic injury This has real clinical implications: if you use nicotine and then undergo surgery or experience a medical event that temporarily cuts blood flow to the kidneys, the resulting damage could be worse than it would be in someone without nicotine exposure.

E-Cigarettes, Pouches, and Other Non-Combustible Nicotine Sources

A common assumption is that switching from cigarettes to e-cigarettes or nicotine pouches eliminates the kidney risk because you are no longer inhaling tar, carbon monoxide, and thousands of combustion byproducts. The reality is less reassuring. A systematic review of vaping studies found that e-cigarette users showed elevated creatinine levels and declining filtration rates compared to non-users, with the risks of both acute kidney injury and chronic kidney disease progression significantly higher among vapers than non-smokers, though roughly comparable to conventional cigarette smokers.15PubMed Central. Effects of vaping on kidney function: a systematic review on acute kidney injury and chronic kidney disease

A nationally representative cohort study found that e-cigarette use was associated with roughly 2.5-fold higher odds of chronic kidney disease, with a clear dose-response pattern: people who vaped one to two days per week had about 1.8 times the odds, while those vaping three or more days per week had about 2.6 times the odds.16PubMed Central. Electronic cigarette use and risk of chronic kidney disease: a dose-response analysis with propensity score matching in a nationally representative cohort A separate review noted that cross-sectional studies have found associations between vaping and kidney damage markers in adolescents and young adults, though the evidence base remains limited and animal studies are still catching up.17PubMed. E-cigarettes and kidney health: current knowledge and future perspectives

Oral nicotine products are even less studied, but a case report described a 19-year-old kidney transplant recipient who developed severe acute tubular necrosis after using nicotine pouches, leading to a lasting decline in kidney function (filtration rate around 35 at eight months of follow-up).18PubMed Central. Association of Oral Tobacco-Free Nicotine Delivery Product with Audit Renal Tubular Necrosis One case cannot establish causation, but in the context of everything else known about nicotine’s kidney effects, it fits the expected pattern. The bottom line is that nicotine itself, regardless of the delivery vehicle, has biological mechanisms that harm kidney tissue. Removing combustion products likely reduces total risk, but it does not zero it out.

What Happens When You Quit

The encouraging part of this story is that quitting appears to substantially reduce the risk. In a Japanese study of healthy working-age adults followed over time, those who continued smoking had roughly 2.5 times the odds of developing proteinuria (a key marker of early kidney disease) compared to non-smokers, while those who quit dropped to odds that were not significantly different from non-smokers.19PubMed Central. The effects of continuing and discontinuing smoking on the development of chronic kidney disease (CKD) in the healthy middle-aged working population in Japan A meta-analysis of prospective studies found that the elevated risk of kidney failure in male smokers remained significant even one to nine years after quitting, but by ten or more years after quitting, the risk had dropped to essentially the same level as never-smokers.20Nephrology Dialysis Transplantation. Cigarette smoking and chronic kidney disease in the general population: a systematic review and meta-analysis of prospective cohort studies

That timeline matters. The kidney is not as forgiving as, say, the lungs, where measurable improvements in airway function begin within weeks. Kidney recovery from smoking-related damage is a slower process, and for people who already have moderate-to-advanced chronic kidney disease, quitting slows progression but may not reverse established scarring. Still, the data consistently show that quitting is the single most impactful intervention a smoker with kidney disease can make.

Kidney Transplant Recipients Face Especially High Stakes

For people who have received a kidney transplant, nicotine exposure is an even bigger concern. In a post hoc analysis of a large transplant trial, current smokers had a roughly 50% greater risk of graft loss and a more than doubled risk of non-cardiovascular death compared with never-smokers. Former smokers who had quit before transplant did not carry that excess graft-loss risk.21PubMed Central. Smoking and outcomes in kidney transplant recipients: a post hoc survival analysis of the FAVORIT trial An analysis of the United States Renal Data System found that picking up smoking after a transplant was associated with a 46% increase in the risk of losing the transplanted kidney and more than double the risk of death.22Transplantation. Effect of Smoking on Kidney Transplant Outcomes: Analysis of the United States Renal Data System

Even a history of smoking before the transplant leaves a mark. A retrospective study found that former smokers had a 60% higher risk of graft loss and more than double the risk of losing the graft for non-death reasons, compared to never-smokers. Kidney function as measured by filtration rate declined faster over time in former smokers than in never-smokers.23PubMed. Former smoking and early and long-term graft outcome in renal transplant recipients: a retrospective cohort study Transplant programs typically require candidates to quit before listing, and these numbers explain why that requirement is medically grounded rather than arbitrary.

Nicotine During Pregnancy and Fetal Kidney Development

The kidney effects of nicotine are not limited to the person using it. In pregnant rats exposed to nicotine, offspring showed permanently reduced kidney weight relative to body weight, a difference that persisted from early postnatal life all the way to adulthood. While body weight eventually caught up through compensatory growth, kidney weight did not.24PubMed Central. The effect of fetal and neonatal nicotine exposure on renal development of AT1 and AT2 receptors This is significant because kidney size correlates with the number of filtering units (nephrons) a person has, and humans do not grow new nephrons after birth. Starting life with fewer nephrons means less reserve capacity and a greater vulnerability to kidney disease later in life. While these findings come from animal studies and cannot be directly translated to humans, they align with broader evidence that prenatal tobacco exposure is linked to smaller kidneys and increased kidney disease risk in children.

How Kidney Disease Changes Nicotine’s Behavior in the Body

There is also a feedback loop worth knowing about. Nicotine harms the kidneys, and impaired kidneys change how nicotine moves through the body. In people with severe kidney failure, the liver’s ability to break down nicotine was roughly halved compared to healthy subjects. Clearance of cotinine, nicotine’s primary metabolite, was also reduced.25PubMed. Pharmacokinetics of nicotine in kidney failure This means that someone with chronic kidney disease who smokes or uses nicotine products will have higher circulating levels of nicotine and cotinine for longer periods than someone with healthy kidneys, effectively increasing their exposure per dose. It is a vicious cycle: nicotine damages the kidneys, and damaged kidneys slow the elimination of nicotine, which then causes more damage at the same usage level. Kidney disease also influences the metabolism of nicotine in broader ways, interacting with age, sex, diet, and medications that many kidney patients are already taking.26PubMed Central. Nicotine chemistry, metabolism, kinetics and biomarkers

For clinicians helping patients with kidney disease quit smoking, this pharmacokinetic shift matters. Nicotine replacement therapy (patches, gum, lozenges) is generally considered safer than continued smoking, but dosing may need adjustment in people with significantly reduced kidney function because the nicotine sticks around longer. A comprehensive review of smoking cessation in the chronic kidney disease population emphasized that individuals with kidney disease face increased cardiovascular risk from smoking and benefit from cessation, while noting the unique challenges this population faces in quitting.27PubMed Central. Helping Patients With ESRD and Earlier Stages of CKD to Quit Smoking The benefits of quitting still far outweigh the risks of carefully managed nicotine replacement, but the conversation between patient and doctor is worth having.

Caitlin Pearson

Caitlin Pearson, RN, is an associate editor at Biology Insights reporting on kidney health. Living in Oxford, Mississippi, she has worked in clinical care since 2014, including time at an outpatient dialysis center. Pearson received her BSN from Minnesota State University, Mankato.